Literature DB >> 2103489

The role of cathepsin L in malignant transformation.

S E Kane1, M M Gottesman.   

Abstract

Procathepsin L is the major excreted protein of malignantly transformed mouse fibroblasts and it is one of the major acid cysteine proteases in mammalian cells. The broad general protease activity of cathepsin L against a variety of extracellular matrix proteins as well as other intracellular protein substrates, and its regulation by factors which stimulate growth, suggest that it contributes to the transformed phenotype. Possible functions in antigen processing, invasiveness, metastasis, and turnover of intracellular and secreted proteins involved in growth regulations have been proposed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2103489

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  29 in total

1.  Improved stability of multivalent antibodies containing the human collagen XV trimerization domain.

Authors:  Angel M Cuesta; David Sánchez-Martín; Ana Blanco-Toribio; Maider Villate; Kelly Enciso-Álvarez; Ana Alvarez-Cienfuegos; Noelia Sainz-Pastor; Laura Sanz; Francisco J Blanco; Luis Alvarez-Vallina
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

2.  Functional expression of recombinant human stefin A in mammalian and bacterial cells.

Authors:  Catharine C Calkins; Julie Dosescu; Nancy A Day; Wei-Ping Ren; Rafael Fridman; Bonnie F Sloane; Kamiar Moin
Journal:  Protein Expr Purif       Date:  2006-12-09       Impact factor: 1.650

3.  Expressions of chromogranin A and cathepsin D in human primary hepatocellular carcinoma.

Authors:  Xiao-Feng Huang; Chun-Mei Wang; Xiao-Wen Dai; Zhen- Jiang Li; Bo-Rong Pan; Li-Bin Yu; Bin Qian; Li Fang
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

4.  Malignant transformation alters intracellular trafficking of lysosomal cathepsin D in human breast epithelial cells.

Authors:  Y Nishimura; M Sameni; B F Sloane
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

5.  Unstimulated human acute myelogenous leukemia blasts secrete matrix metalloproteinases.

Authors:  A Matsuzaki; A Janowska-Wieczorek
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

6.  Cathepsins D, B, and L in transformed human breast epithelial cells.

Authors:  T T Lah; G Calaf; E Kalman; B G Shinde; R Somers; S Estrada; E Salero; J Russo; I Daskal
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Effect of carbohydrate position on lysosomal transport of procathepsin L.

Authors:  R G Lingeman; D S Joy; M A Sherman; S E Kane
Journal:  Mol Biol Cell       Date:  1998-05       Impact factor: 4.138

Review 8.  Anti-invasion drugs.

Authors:  R B Dickson; M D Johnson; M Maemura; J Low
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

9.  Hybridoma cells producing antibodies to cathepsin L have greatly reduced potential for tumour growth.

Authors:  E Weber; D Günther; F Laube; B Wiederanders; H Kirschke
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

10.  Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples.

Authors:  M R Emmert-Buck; M J Roth; Z Zhuang; E Campo; J Rozhin; B F Sloane; L A Liotta; W G Stetler-Stevenson
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.